Medroxyprogesterone Acetate Injection, Suspension
Product Images NDC 60219-1467

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 60219-1467). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Medroxyprogesterone Acetate Injectable Suspensionu 1)

A forest plot chart showing odds ratios with 95% confidence intervals for various studies assessing risk related to Medroxyprogesterone Acetate (DMPA) use. Study names and years are listed on the left, with odds ratios plotted on a logarithmic scale on the x-axis, ranging from 0.6 to 7.4. The chart visualizes increased or decreased risk indicated by odds ratio values above or below 1.0.*

FDA Label Image

Structure (Medroxyprogesterone Acetate Injectable Suspensionu 2)

Chemical structure of Medroxyprogesterone Acetate, showing its steroid backbone with ketone, ester, and methyl groups as depicted in the molecular diagram.*

FDA Label Image

1 (Medroxyprogesterone Acetate Injectable Suspensionu 3)

An illustration showing a vertical arrow indicating pregnancy rates from 'Fewer Pregnancies' at the top to 'More Pregnancies' at the bottom. It lists birth control methods grouped by effectiveness: implants, injections, intrauterine devices, and sterilization at the top; birth control pills, skin patch, and vaginal ring with hormones next; condoms and diaphragm further down; no sex during fertile days, spermicide, and withdrawal below that; and no birth control at the bottom. Pregnancy rates are indicated as fewer than 1, 10-20, or 85 or more pregnancies per 100 women in one year.*

FDA Label Image

1 (Medroxyprogesterone Acetate Injectable Suspensionu 4)

Label for Medroxyprogesterone Acetate Injectable Suspension USP 150 mg/mL single-dose vial. The label indicates it is a contraceptive injection for intramuscular use only, distributed by Amneal Pharmaceuticals LLC and made in India. The label includes directions to shake before use, lot and expiration date fields, and a barcode on the right.*

FDA Label Image

1 (Medroxyprogesterone Acetate Injectable Suspensionu 5)

Packaging label for Medroxyprogesterone Acetate 150 mg/mL Injectable Suspension, USP by Amneal Pharmaceuticals NY LLC. This single-dose 1 mL vial is indicated for contraceptive injection via intramuscular use. The label includes storage instructions, ingredients, and manufacturer details from Senador Laboratories Private Limited, India, with a barcode and NDC 60219-1467.*

FDA Label Image

1 (Medroxyprogesterone Acetate Injectable Suspensionu 6)

Packaging label for Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg/mL by Amneal Pharmaceuticals NY LLC. The label indicates this human prescription drug is a contraceptive injection for intramuscular use, supplied in 25 single-dose 1 mL vials. Storage instructions specify keeping vials upright at 20° to 25°C (68° to 77°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.